Zhejiang Medicine Co Ltd (600216) — Free Cash Flow Generation Index
Zhejiang Medicine Co Ltd (600216) has a Free Cash Flow Generation Index of 0.88x as of September 2025. Free cash flow of CN¥610.74 Million represents 1% of operating cash flow (CN¥690.77 Million). Explore 600216 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Zhejiang Medicine Co Ltd Free Cash Flow Generation Index (1998–2025)
Historical FCF Generation Index trend for Zhejiang Medicine Co Ltd across 27 annual periods. For the full cash flow conversion analysis, see Zhejiang Medicine Co Ltd cash conversion from operations.
Annual Free Cash Flow Generation for Zhejiang Medicine Co Ltd (1998–2025)
Year-by-year Free Cash Flow Generation Index for Zhejiang Medicine Co Ltd. Check 600216 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.76x | CN¥1.44 Billion | CN¥1.89 Billion | CN¥446.47 Million | ▲ +74.8% |
| 2024 | 0.44x | CN¥534.15 Million | CN¥1.22 Billion | CN¥689.14 Million | ▲ +270.4% |
| 2023 | -0.26x | CN¥-162.56 Million | CN¥634.31 Million | CN¥796.87 Million | ▲ +70.7% |
| 2022 | -0.87x | CN¥-455.39 Million | CN¥520.60 Million | CN¥975.99 Million | ▼ -604.6% |
| 2021 | 0.17x | CN¥197.05 Million | CN¥1.14 Billion | CN¥939.60 Million | ▼ -69.8% |
| 2020 | 0.57x | CN¥721.37 Million | CN¥1.26 Billion | CN¥535.35 Million | ▲ +303.1% |
| 2019 | -0.28x | CN¥-126.38 Million | CN¥447.25 Million | CN¥573.63 Million | ▼ -216.5% |
| 2018 | 0.24x | CN¥140.61 Million | CN¥579.91 Million | CN¥439.30 Million | ▲ +283.5% |
| 2017 | -0.13x | CN¥-66.52 Million | CN¥503.47 Million | CN¥569.99 Million | ▲ +2.7% |
| 2016 | -0.14x | CN¥-45.63 Million | CN¥336.14 Million | CN¥381.76 Million | ▲ +97.7% |
| 2015 | -5.80x | CN¥-618.42 Million | CN¥106.54 Million | CN¥724.96 Million | ▼ -622.4% |
| 2014 | -0.80x | CN¥-441.86 Million | CN¥549.90 Million | CN¥991.76 Million | ▲ +1.1% |
| 2013 | -0.81x | CN¥-532.38 Million | CN¥655.09 Million | CN¥1.19 Billion | ▼ -375.5% |
| 2012 | -0.17x | CN¥-138.01 Million | CN¥807.49 Million | CN¥945.50 Million | ▼ -127.5% |
| 2011 | 0.62x | CN¥568.17 Million | CN¥912.75 Million | CN¥344.58 Million | ▼ -30.0% |
| 2010 | 0.89x | CN¥1.17 Billion | CN¥1.32 Billion | CN¥145.90 Million | ▼ -0.7% |
| 2009 | 0.90x | CN¥1.31 Billion | CN¥1.47 Billion | CN¥153.13 Million | ▲ +0.5% |
| 2008 | 0.89x | CN¥1.07 Billion | CN¥1.20 Billion | CN¥130.27 Million | ▲ +173.2% |
| 2007 | 0.33x | CN¥74.30 Million | CN¥227.67 Million | CN¥153.37 Million | ▲ +168.7% |
| 2006 | -0.47x | CN¥-80.48 Million | CN¥169.51 Million | CN¥249.99 Million | ▲ +96.2% |
| 2005 | -12.60x | CN¥-316.79 Million | CN¥25.14 Million | CN¥341.93 Million | ▼ -3544.1% |
| 2004 | -0.35x | CN¥-37.20 Million | CN¥107.60 Million | CN¥144.80 Million | ▲ +64.9% |
| 2003 | -0.98x | CN¥-65.17 Million | CN¥66.20 Million | CN¥131.37 Million | ▲ +88.1% |
| 2002 | -8.25x | CN¥-190.69 Million | CN¥23.13 Million | CN¥213.81 Million | ▼ -3550.0% |
| 2001 | -0.23x | CN¥-22.19 Million | CN¥98.25 Million | CN¥120.44 Million | ▲ +97.9% |
| 2000 | -10.69x | CN¥-113.11 Million | CN¥10.58 Million | CN¥123.69 Million | ▼ -802.3% |
| 1998 | -1.18x | CN¥-68.37 Million | CN¥57.72 Million | CN¥126.08 Million | — |